Employee brief · 2 min read
Green flag
Tempus AI wins up to $9.5 million to develop an autonomous cardiology agent
Tempus AI was selected for an ARPA-H award of up to $9.5 million to build and clinically validate an autonomous AI agent for heart-failure care. The program includes a multi-center prospective study and builds on existing Tempus clinical AI products.
Candidate lensConstructive signal
Leans toward opportunityOpportunityContextRisk
Company context
The wider Tempus AI picture.
Work outlook71/100Positive
Signal mix
TAExplore the evidenceFull company profile↗1 positive0 mixed0 caution
Signal snapshot
01Event typeInvestment
02Event dateSep 9, 2026
03Reported scopeUnited States
04Source confidenceHigh
What this means for employees
This creates a defined, externally funded program for clinical AI, data integration, validation and regulated-product work. The award is capped at up to $9.5 million, so candidates should verify project duration, funding milestones and whether the role is attached to the program.
01
Flags verdict
Worth a closer look
This is a constructive signal for candidates. Confirm that the position is approved, net-new and supported beyond the current quarter.
Ask this in the interview
Is this role funded by the ARPA-H program, and which clinical-validation or product milestone determines its budget and duration?
Editorial standard Flags separates confirmed facts from candidate-focused interpretation. The original source is always linked alongside the analysis. Read our methodology →